Saffron; An updated review on biological properties with special focus on cardiovascular effects - 09/12/18
, Neda Roshanravan ⁎ Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 7 |
| Iconographies | 2 |
| Vidéos | 0 |
| Autres | 0 |
Highlights |
• | Saffron provides a variety of promising preventive and therapeutic effects on cardiovascular disease. |
• | Saffron and its components can modulate various cardiovascular risk factors such as oxidative stress, atherosclerosis and inflammation. |
• | Pharmacological effects of saffron are mainly attributed to its cellular and molecular effects. |
Abstract |
Objective |
Saffron as a natural product has long been used to impede and treat different disorders including cardiovascular disease (CVDs). Stigma is the most principal part of saffron. Various compounds such as carotenoids and flavonoids are the essential components of saffron stigma. The health benefits of saffron have been shown in previous studies; however, there is a lack of comprehensive data on the mechanistic aspects of its cardiovascular-health properties. This current comprehensive review focuses on the medicinal applications of saffron, and then the new findings regarding its cardiovascular-health effects and various cellular and molecular mechanisms of action will be debated.
Methods |
The literature search of MEDLINE, Embase, PubMed, Google Scholar and Cochrane Library was performed for all comparative studies since 2000–2018 with the limitations of the English language.
Results |
The results provided new evidence about antioxidant, anti-inflammatory, anti- atherogenic, anti- apoptotic, anti- hypertensive, and hypolipidemic effects of saffron. Pharmacological effects of saffron are due to a number of ingredients contained within this spice, including safranal, crocetin and crocins.
Conclusions |
Our study concludes that saffron with wide range of usefulness in medicine may be the potent candidate in the process of new drug production for the treatment of CVDs.
Le texte complet de cet article est disponible en PDF.Abbreviations : CVDs, CCD, ROS, NOS, NADPH, GR, c-GCS, GSH, MDA, NO, CK-MB, HBP, CHD, ERK1/2, CETP, LD
Keywords : Cardiovascular disease, Saffron, Carotenoids, Antioxidant
Plan
Vol 109
P. 21-27 - janvier 2019 Retour au numéro
Article précédent
- Occurrence, chemical composition, biological activities and analytical methods on Copaifera genus—A review
- Caroline Arruda, Jennyfer Andrea Aldana Mejía, Victor Pena Ribeiro, Carly Henrique Gambeta Borges, Carlos Henrique Gomes Martins, Rodrigo Cássio Sola Veneziani, Sérgio Ricardo Ambrósio, Jairo Kenupp Bastos
- Chemoresistance caused by the microenvironment of glioblastoma and the corresponding solutions
- Xin Zhang, Kaikai Ding, Jian Wang, Xingang Li, Peng Zhao
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?